San Francisco, California, USA, Aug. 01, 2025 (GLOBE NEWSWIRE) — US Capital Global is pleased to announce the expansion of its London office with the addition of three senior bankers: Managing Director Michael Silberberg, Managing Director Mark Olson, and Vice President James Bowles. These seasoned professionals bring decades of expertise across investment banking, private equity, […]
First American Properties CEO Michael S. Eisenga: Labor Market Data Offers Stark Warning of Impending U.S. Recession GlobeNewswire August 01, 2025 COLUMBUS, Wis., Aug. 01, 2025 (GLOBE NEWSWIRE) — Michael S. Eisenga, CEO of First American Properties LLC, has issued a sober assessment of the U.S. economy following the latest July employment report, calling the
US Capital Global Expands Regional Office in London with Three Senior Appointments As part of its European growth strategy, US Capital Global welcomes Michael Silberberg, Mark Olson, and James Bowles to strengthen its middle-market financing team. GlobeNewswire August 01, 2025 San Francisco, California, USA, Aug. 01, 2025 (GLOBE NEWSWIRE) — US Capital Global is pleased
Clinical Stage Biotechnology Company Uses Patient Immune System to “Seek and Destroy” Cancer and Metastasis Res Nova Biologics, a clinical stage cancer immunotherapy company focused on developing small molecules and cellular products as non-toxic cancer therapies, announced today the appointment of Allan Camaisa, former Chairman and CEO and cofounder of Calidi Biotherapeutics to its Advisory
Mazda Canada Inc. (MCI) today reported July sales of 7,966 vehicles, representing an increase of 14.5 percent versus July 2024. Sales year-to-date (YTD) are 47,747, which is an increase of 19.5 percent compared to the same period in 2024. JULY 2025 HIGHLIGHTS: — Mazda3 sales jumped 126.7 percent versus July 2024. — CX-30 sales jumped
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=159304&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Barnes & Noble Education, Inc. ("Barnes & Noble Education, Inc.") (NYSE:BNED) concerning possible violations of federal securities laws. Barnes & Noble disclosed in a filing on July 18, 2025, with the U.S.
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of The J. M. Smucker Company ("The J. M. Smucker Company") (NYSE:SJM) concerning possible violations of federal securities laws. On June 9, 2025, Smucker announced its fourth quarter and full fiscal year 2025
Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that Professor Seth Cohen, Ph.D., the company's academic co-founder, presented a Keynote Talk at the 21st International Conference on Biological Inorganic Chemistry
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=159301&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or